国际期刊CACA-Lancet
日期：2024年11月16日
地点：西安国际会展中心会议楼二层多功能厅D
| 时间 | 题目 | 讲者 | 单位 |
|---|---|---|---|
| 13:00-13:20 |
Publishing in the Lancet Journals |
蔡杰 | LANCET Regional Health – Western Pacific |
| 13:20-13:40 |
Why would my high-quality research be rejected |
陈家亮 | 香港中文大学 |
| 13:40-14:00 |
Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial |
刘需 | 中山大学肿瘤防治中心 |
| 14:00-14:20 |
Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial |
季科 | 北京大学肿瘤医院 |
| 14:20-14:50 |
讨论 |
||
| 时间 | 题目 | 讲者 | 单位 |
|---|---|---|---|
| 15:00-15:20 |
TACE with or without lenvatinib + pembrolizumab for intermediate-stage hepatocellular carcinoma |
韩国宏 | 西安国际医学中心医院 |
| 15:20-15:40 |
Interpretable multi-modal artificial intelligence model for predicting gastric cancer response to neoadjuvant chemotherapy |
肖琼 | 中国医科大学附属第一医院 |
| 15:40-16:00 |
Surgical resection of thymic epithelial tumors invading superior vena cava without venous reconstruction under internal jugular vein pressure monitoring |
郝秀秀 | 上海市胸科医院 |
| 16:00-16:30 |
讨论 |
||
美迪康会务通